State Street’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$177M Buy
3,207,543
+500,924
+19% +$27.7M 0.01% 988
2025
Q1
$131M Sell
2,706,619
-624,442
-19% -$30.2M 0.01% 1128
2024
Q4
$129M Buy
3,331,061
+147,519
+5% +$5.69M 0.01% 1189
2024
Q3
$143M Buy
3,183,542
+1,101,218
+53% +$49.6M 0.01% 1113
2024
Q2
$72.2M Sell
2,082,324
-1,190,161
-36% -$41.2M ﹤0.01% 1459
2024
Q1
$94.7M Buy
3,272,485
+542,556
+20% +$15.7M ﹤0.01% 1347
2023
Q4
$62.6M Sell
2,729,929
-1,212,209
-31% -$27.8M ﹤0.01% 1579
2023
Q3
$65.8M Buy
3,942,138
+390,152
+11% +$6.51M ﹤0.01% 1449
2023
Q2
$98.1M Buy
3,551,986
+1,138,285
+47% +$31.4M 0.01% 1234
2023
Q1
$55.5M Sell
2,413,701
-1,379,225
-36% -$31.7M ﹤0.01% 1586
2022
Q4
$41.4M Sell
3,792,926
-883,756
-19% -$9.64M ﹤0.01% 1766
2022
Q3
$39.4M Sell
4,676,682
-2,099,587
-31% -$17.7M ﹤0.01% 1770
2022
Q2
$53.6M Buy
6,776,269
+3,519,461
+108% +$27.8M ﹤0.01% 1594
2022
Q1
$77.1M Buy
3,256,808
+685,238
+27% +$16.2M ﹤0.01% 1479
2021
Q4
$87.9M Buy
2,571,570
+557,591
+28% +$19.1M ﹤0.01% 1396
2021
Q3
$35.7M Buy
2,013,979
+559,359
+38% +$9.91M ﹤0.01% 2048
2021
Q2
$65.3M Sell
1,454,620
-258,063
-15% -$11.6M ﹤0.01% 1650
2021
Q1
$44.4M Buy
1,712,683
+228,367
+15% +$5.91M ﹤0.01% 1824
2020
Q4
$29.9M Buy
1,484,316
+329,763
+29% +$6.65M ﹤0.01% 1982
2020
Q3
$22.6M Buy
1,154,553
+771,659
+202% +$15.1M ﹤0.01% 1968
2020
Q2
$6.76M Buy
382,894
+65,102
+20% +$1.15M ﹤0.01% 2620
2020
Q1
$2.24M Sell
317,792
-20,378
-6% -$144K ﹤0.01% 3011
2019
Q4
$2.38M Buy
338,170
+23,127
+7% +$163K ﹤0.01% 3191
2019
Q3
$3.78M Buy
315,043
+52,333
+20% +$629K ﹤0.01% 2929
2019
Q2
$3.18M Buy
262,710
+248,658
+1,770% +$3.01M ﹤0.01% 3050
2019
Q1
$177K Sell
14,052
-246
-2% -$3.1K ﹤0.01% 3588
2018
Q4
$96K Sell
14,298
-342
-2% -$2.3K ﹤0.01% 3637
2018
Q3
$151K Buy
14,640
+262
+2% +$2.7K ﹤0.01% 3620
2018
Q2
$96K Sell
14,378
-138,604
-91% -$925K ﹤0.01% 3634
2018
Q1
$1.31M Buy
152,982
+16,138
+12% +$139K ﹤0.01% 3293
2017
Q4
$2.85M Buy
136,844
+19,661
+17% +$409K ﹤0.01% 3050
2017
Q3
$2.07M Buy
117,183
+4,709
+4% +$83.2K ﹤0.01% 3191
2017
Q2
$1.27M Buy
112,474
+19,411
+21% +$219K ﹤0.01% 3288
2017
Q1
$1.19M Buy
93,063
+900
+1% +$11.5K ﹤0.01% 3227
2016
Q4
$2.03M Buy
92,163
+31,042
+51% +$683K ﹤0.01% 3097
2016
Q3
$1.29M Buy
+61,121
New +$1.29M ﹤0.01% 3124